Skip to main content
33kviews
Editorial25 May 2023
Editorial: Thyroid hormone actions in cancer

The knowledge of the mechanisms of THs actions in cancer could lead to the identification of new therapeutic targets or to the use of the modulation of the thyroid status to improve treatment outcomes in patients. The overall aim of this special issue entitled "Thyroid hormone actions in cancer" includes the contribution and significance of TH´s direct actions on tumor cell proliferation, survival and dissemination; and the association of thyroid status with the risk and progression of oncologic pathologies. This Research Topic consists of two original research articles, one review and one systematic review. These articles include the study of hepatocellular carcinoma, glioblastoma, thyroid cancer, and pituitary adenoma as the research oncologic models.In the first original paper Godugu et al, evaluated if TH analogues have a role in efferocytosis, a process by which apoptotic cells are removed by phagocytic cells. Using in vitro and in vivo glioblastoma models authors examined how the apoptosis induced by the hormone analogue tetraiodothyroacetic acid (tetrac) and chemically modified tetrac actions initiated at the integrin αvβ3 on tumor cells, contribute to the clearance of apoptotic cells. In the other original research article, Lu et al used Mendelian randomization (MR) analysis to estimate the causal effect of hypothyroidism on the risk for hepatocellular carcinoma (HCC). Single-nucleotide polymorphisms (SNPs) associated with hypothyroidism were screened via a genome-wide association study (GWAS). They found that hypothyroidism has a protective causal association with HCC. On the other hand, Wang et al performed a systematic review of related original studies with the purpose of comprehensively evaluating the relationships between thyroid-related hormones and the risk of thyroid cancer (TC). The authors found a significant association between thyroid-related hormones (TSH, free T4, free T3) and the risk of TC in this study, but further research is needed to understand the underlying mechanisms. Finally, Li et al showed a rare case of pituitary adenoma producing both GH and TSH simultaneously, which is associated with hyperthyroidism and acromegaly.

2,330 views

2 citations

Hypothyroidism has a protective causal association with hepatocellular carcinoma: A two-sample Mendelian randomization study
Objective: Observational studies suggest an association between hypothyroidism and the risk of hepatocellular carcinoma (HCC), but the causality and direction of these effects are still inconclusive. We aim to test whether hypothyroidism is causally associated with the risk of HCC by using Mendelian randomization (MR) analysis. Methods: Single-nucleotide polymorphisms (SNPs) associated with hypothyroidism were screened via a genome-wide association study (GWAS) with 337,159 European-descent individuals. Summary-level data for HCC (372,184 individuals) were extracted from UK Biobank. An inverse-variance-weighted (IVW) method was used as the primary MR analysis. Sensitivity analyses were examined via MR-Egger regression, heterogeneity test, pleiotropy test, and leave-one-out sensitivity test. The assumption that exposure causes outcome was verified using the MR Steiger test. Results: Two-Sample MR analysis showed inverse associations between genetically predicted hypothyroidism and HCC risk (OR = 0.997, 95% CI, 0.995-0.999; P = 0.016). There were no statistical indications of heterogeneity between instruments (P-het = 0.667). Across five MR methods, genetically predicted hypothyroidism shows a consistent correlation with HCC. The leave-one-out analysis indicated that no single SNP changed the overall estimate (P = 0.016). In addition, the MR Steiger test revealed that the hypothyroidism effect on HCC was the proper causal direction (P = 0.000). Conclusion: Genetic variants predisposing to hypothyroidism were associated with lower HCC risk. Further research is required to comprehend the mechanisms underlying this putative causative association, and follow-up clinical trials need to be conducted to establish whether inducing hypothyroidism could be beneficial for HCC patients.

7,562 views

41 citations

The associations between thyroid-related hormones and the risk of thyroid cancer: An overall and dose-response meta-analysis
SYSTEMATIC REVIEW
7 December 2022
The associations between thyroid-related hormones and the risk of thyroid cancer: An overall and dose-response meta-analysis
Zheng Wang, 4 more and Qian Zhang
Objective: Thyroid cancer (TC) is one of the most common malignant tumours of the endocrine system. Thyroid-stimulating hormone (TSH) is known as being a risk factor for TC, but other thyroid-related hormones are inconsistently associated with TC. The purpose of this study was to comprehensively evaluate the relationships between thyroid-related hormones and the risk of TC. Methods: This study utilized searches of PubMed, Embase, Web of Science and Cochrane library up to the date of March 31st, 2022. Additionally, we performed a systematic review of related original studies combining overall and dose–response meta-analyses. Results: A total of 30, 5 and 7 articles were included in the meta-analyses of TSH, Free triiodothyronine (FT3), free thyroxine (FT4) and TC risk with 58437, 6813 and 7118 participants respectively. An increased risk of TC was associated with high TSH exposure (OR=1.28, 95% CI: 1.19-1.37, P<0.001) in the overall meta-analysis. For every 1 mU/L increase in TSH, the risk of TC increased by 16%. However, in those studies that used healthy subjects as controls, the association was not statistically significant(P=0.62). Additionally, high serum FT3 demonstrated a reduced risk of TC, with a combined OR of 0.86 in the fixed-effect model (95% CI: 0.81–0.90, P<0.001). In addition, a statistically significant increase in TC risk was found when FT4 concentrations reached a certain threshold (approximately 2.2 ng/dL) in the dose-response meta-analysis. Conclusions: Significant associations between thyroid-related hormones and the risk of TC were found in this study. Further research is needed to understand the underlying mechanisms.

5,574 views

30 citations

REVIEW
23 December 2022
A rare pituitary tumor associated with hyperthyroidism and acromegaly
Li Li, 8 more and Yingfen Qin

6,996 views

6 citations